Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Bellerophon Therapeutics ...

    NASDAQ: BLPH · Real-Time Price · USD
    0.01
    -0.01 (-47.37%)
    At close: Dec 18, 2024, 5:51 PM

    Bellerophon Therapeutics Statistics

    Share Statistics

    Bellerophon Therapeutics has 12.23M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 12.23M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 1.71%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 217,078

    FTD / Avg. Volume

    n/a
    		 1.59K%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -0.43 and the forward PE ratio is null. Bellerophon Therapeutics's PEG ratio is -0.04.

    PE Ratio

    n/a
    		 -0.43

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 3.39

    P/FCF Ratio

    n/a
    		 -0.48

    PEG Ratio

    n/a
    		 -0.04
    Financial Ratio History

    Enterprise Valuation

    Bellerophon Therapeutics has an Enterprise Value (EV) of 1.87M.

    EV / Sales

    n/a
    		 0

    EV / EBITDA

    n/a
    		 -0.08

    EV / EBIT

    n/a
    		 -0.11

    EV / FCF

    n/a
    		 -0.11

    Financial Position

    The company has a current ratio of 1.4, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 1.4

    Quick Ratio

    n/a
    		 1.4

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 -165.81

    Financial Efficiency

    Return on Equity is -782.6% and Return on Invested Capital is -787.38%.

    Return on Equity

    n/a
    		 -782.6%

    Return on Assets

    n/a
    		 -249.92%

    Return on Invested Capital

    n/a
    		 -787.38%

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,101,722.22

    Employee Count

    n/a
    		 18

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -2.42M

    Effective Tax Rate

    n/a
    		 10.86%

    Stock Price Statistics

    The stock price has increased by -81.52% in the last 52 weeks. The beta is 0.7, so Bellerophon Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.7

    52-Week Price Change

    n/a
    		 -81.52%

    50-Day Moving Average

    n/a
    		 0.04

    200-Day Moving Average

    n/a
    		 0.05

    Relative Strength Index (RSI)

    n/a
    		 27.71

    Average Volume (20 Days)

    n/a
    		 13,687

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -65K

    Operating Income

    n/a
    		 -22.38M

    Net Income

    n/a
    		 -19.83M

    EBITDA

    n/a
    		 -22.18M

    EBIT

    n/a
    		 -22.25M

    Earnings Per Share (EPS)

    n/a
    		 -2.08
    Full Income Statement

    Balance Sheet

    The company has 6.92M in cash and 203K in debt, giving a net cash position of 6.72M.

    Cash & Cash Equivalents

    n/a
    		 6.92M

    Total Debt

    n/a
    		 203K

    Net Cash

    n/a
    		 6.72M

    Retained Earnings

    n/a
    		 -252.08M

    Total Assets

    n/a
    		 4.98M

    Working Capital

    n/a
    		 3.72M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -17.77M and capital expenditures 0, giving a free cash flow of -17.77M.

    Operating Cash Flow

    n/a
    		 -17.77M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -17.77M

    FCF Per Share

    n/a
    		 -1.86
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    BLPH does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -230.71%

    FCF Yield

    n/a
    		 -206.73%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for BLPH.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Feb 10, 2020. It was a backward split with a ratio of 1:15.

    Last Split Date

    n/a
    		 Feb 10, 2020

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:15

    Scores

    Altman Z-Score

    n/a
    		 -77.24

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist